Skip to main content
. 2018 Nov 6;6(Suppl 1):115. doi: 10.1186/s40425-018-0423-x

Fig. 4 (abstract P567).

Fig. 4 (abstract P567).

Incidence of Grade 3-5 Adverse Events Pembrolizumab